Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment

Summary

The study will be non randomized, open label, dose rising study in cancer patients. Cancer treatment is consisting of 2 different drugs: Oshadi D and Oshadi R that will be administered orally. The study will include two sessions: * A single dose period to evaluate acute toxicity of each drug * Consecutive multiple increment dose escalation period of both drugs to determine the long-term safety, and the anticancer activity.

Timeline

Start

2011-01

Primary completion

2012-05

Completion

2012-05

Drugs

Indications